Tech Company Financing Transactions
BioCardia Funding Round
BioCardia closed a $4 million venture capital round on 1/9/2019. Investors included private investors.
Transaction Overview
Company Name
Announced On
1/9/2019
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 3 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
125 Shoreway Rd. B
San Carlos, CA 94070
USA
San Carlos, CA 94070
USA
Phone
Website
Email Address
Overview
BioCardia's Helix Biotherapeutic Delivery business remains committed to being the platform of choice for delivery of therapeutic agents to themyocardium.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Altman
Chief Financial Officer
David McClung
Chief Medical Officer
Eric Duckers
Chief Scientific Officer
Ian McNiece
VP - Bus. Development
Jeffrey Emery
VP - Operations
Phil Pesta
Browse more venture capital transactions:
Prev: 1/9/2019: Forefront Telecare venture capital transaction
Next: 1/9/2019: Carson Living venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to document every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs